Bordeaux, France – October 20, 2020. – FineHeart, SA, a preclinical-stage medical device

company developing an Implantable Cardiac Output Management System (ICOMS) to address

the unmet need of patients suffering from severe heart failure, today announced the successful

completion of a 30-day preclinical study. The 30-day trial confirms the device’s ability to provide

hemodynamic performance with pulsed and continuous increased cardiac output of up to 6L/min;

it demonstrated a low risk of hemolysis and thrombosis.